Drugs / gpASIT+TM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00813046 | Dec 2008 → Jan 2009 | seasonal allergic rhinitis | BioTech Tools S.A. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gpASIT+TM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00813046 ↗ |
| Modality | Peptide | “grass pollen-derived peptides” NCT00813046 ↗ |
| Route | Oral | “oral administration of entero-coated capsules” NCT00813046 ↗ |